• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Must research benefit human subjects if it is to be permissible?若要使研究被允许,它就必须造福人类受试者吗?
J Med Ethics. 2017 Feb;43(2):114-117. doi: 10.1136/medethics-2015-103123. Epub 2016 Aug 29.
2
Research ethics and the medical profession. Report of the Advisory Committee on Human Radiation Experiments.研究伦理与医学专业。人体辐射实验咨询委员会报告。
JAMA. 1996 Aug 7;276(5):403-9.
3
Microbicide research in developing countries: have we given the ethical concerns due consideration?发展中国家的杀微生物剂研究:我们是否对伦理问题给予了充分考虑?
BMC Med Ethics. 2007 Sep 19;8:10. doi: 10.1186/1472-6939-8-10.
4
First-in-human HIV-remission studies: reducing and justifying risk.首次人体HIV缓解研究:降低风险并证明其合理性。
J Med Ethics. 2017 Feb;43(2):78-81. doi: 10.1136/medethics-2015-103115. Epub 2016 May 3.
5
The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction.临床研究中的获益/风险比挑战,以及治愈艾滋病的案例:引言
J Med Ethics. 2017 Feb;43(2):65-66. doi: 10.1136/medethics-2016-103427. Epub 2016 May 23.
6
Informed consent to HIV cure research.对艾滋病治愈研究的知情同意。
J Med Ethics. 2017 Feb;43(2):108-113. doi: 10.1136/medethics-2015-103122. Epub 2016 Jun 10.
7
Research ethics.研究伦理。
West Indian Med J. 1995 Dec;44(4):115-8.
8
Informed Consent and the Disclosure of Clinical Results to Research Participants.知情同意与向研究参与者披露临床结果
Am J Bioeth. 2017 Jul;17(7):58-60. doi: 10.1080/15265161.2017.1328532.
9
Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio.契约主义推理、HIV治愈临床试验以及风险/收益比的道德(不)相关性。
J Med Ethics. 2017 Feb;43(2):124-127. doi: 10.1136/medethics-2015-103127. Epub 2016 Sep 2.
10
The Nuremberg Code: Hippocratic ethics and human rights.《纽伦堡法典》:希波克拉底伦理与人权。
Lancet. 1998 Mar 28;351(9107):974-7. doi: 10.1016/S0140-6736(05)60641-1.

引用本文的文献

1
Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.共识驱动的 SPIRIT 和 CONSORT 扩展在早期阶段剂量发现试验中的发展:DEFINE 研究。
BMC Med. 2023 Jul 5;21(1):246. doi: 10.1186/s12916-023-02937-0.
2
Release of HMGB1 and Toll-like Receptors 2, 4, and 9 Signaling Are Modulated by subsp. BB-12 and Typhimurium in a Gnotobiotic Piglet Model of Preterm Infants.BB-12 亚种和鼠伤寒沙门氏菌通过早产婴儿的无菌猪模型调节 HMGB1 和 Toll 样受体 2、4 和 9 信号的释放。
Int J Mol Sci. 2023 Jan 24;24(3):2329. doi: 10.3390/ijms24032329.
3
Reviewing fair subject selection considerations for the unique case of post sequelae COVID-19 translational studies.审视针对新冠后遗症转化研究这一独特案例的公平受试者选择考量因素。
J Clin Transl Sci. 2022 Jul 7;6(1):e91. doi: 10.1017/cts.2022.425. eCollection 2022.
4
Ethics of HIV cure research: an unfinished agenda.HIV 治愈研究的伦理问题:一个未竟的议程。
BMC Med Ethics. 2021 Jun 30;22(1):83. doi: 10.1186/s12910-021-00651-1.
5
Is There an Ethical Upper Limit on Risks to Study Participants?研究参与者所面临的风险是否存在伦理上限?
Public Health Ethics. 2020 Nov 3;13(2):143-156. doi: 10.1093/phe/phaa028. eCollection 2020 Jul.
6
The psychology of "cure" - unique challenges to consent processes in HIV cure research in South Africa.“治愈”的心理——南非 HIV 治愈研究中同意过程面临的独特挑战。
BMC Med Ethics. 2019 Jan 24;20(1):9. doi: 10.1186/s12910-019-0348-z.
7
Ethical issues in HIV remission trials.HIV 缓解试验中的伦理问题。
Curr Opin HIV AIDS. 2018 Sep;13(5):422-427. doi: 10.1097/COH.0000000000000489.
8
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.HIV 治愈研究中断治疗试验的伦理学:解决风险/效益评估的难题。
J Med Ethics. 2018 Apr;44(4):270-276. doi: 10.1136/medethics-2017-104433. Epub 2017 Nov 10.
9
Perceptions of Equipoise, Risk-Benefit Ratios, and "Otherwise Healthy Volunteers" in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry.美国早期HIV治愈研究背景下对 equipoise(均衡性)、风险效益比及“其他健康志愿者”的认知:一项定性研究
J Empir Res Hum Res Ethics. 2018 Feb;13(1):3-17. doi: 10.1177/1556264617734061. Epub 2017 Oct 6.

本文引用的文献

1
Ethical issues in research with healthy volunteers: risk-benefit assessment.健康志愿者研究中的伦理问题:风险效益评估。
Clin Pharmacol Ther. 2003 Dec;74(6):513-5. doi: 10.1016/j.clpt.2003.08.006.
2
Surgery as placebo. A quantitative study of bias.作为安慰剂的手术。一项关于偏差的定量研究。
JAMA. 1961 Jul 1;176:1102-7. doi: 10.1001/jama.1961.63040260007008.
3
A controlled trial of arthroscopic surgery for osteoarthritis of the knee.膝关节骨关节炎关节镜手术的对照试验。
N Engl J Med. 2002 Jul 11;347(2):81-8. doi: 10.1056/NEJMoa013259.
4
The ethical challenge of infection-inducing challenge experiments.感染诱导挑战实验的伦理挑战。
Clin Infect Dis. 2001 Oct 1;33(7):1028-33. doi: 10.1086/322664. Epub 2001 Sep 5.

若要使研究被允许,它就必须造福人类受试者吗?

Must research benefit human subjects if it is to be permissible?

作者信息

Wikler Daniel

出版信息

J Med Ethics. 2017 Feb;43(2):114-117. doi: 10.1136/medethics-2015-103123. Epub 2016 Aug 29.

DOI:10.1136/medethics-2015-103123
PMID:27573151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5293852/
Abstract

Must medical experiments with human subjects offer them a 'favourable risk-benefit ratio', that is, more expectation of benefit than harm or burden, if they are to be judged as ethically justified? Ethical justification is easier for experiments that do offer net benefit to subjects, but ethical justification is possible also for some experiments that do not. Basic science experiments with healthy volunteers and 'Phase I' drug trials that seek to determine tolerable dosage levels are routinely approved by ethical review committees; moreover, guidance they receive from government funding agencies specifically asks them to weigh risks to subjects against benefits to subjects and also benefits to those who may benefit from the knowledge gained in the experiment. If a puzzle remains, it is why there remains any assumption that research ethics requires a 'favourable risk-benefit ratio' for the individual research subject.

摘要

涉及人类受试者的医学实验若要被判定在伦理上是合理的,就必须为他们提供“有利的风险效益比”,即预期的益处多于伤害或负担吗?对于确实能给受试者带来净益处的实验来说,伦理合理性更容易论证,但对于一些不能带来净益处的实验来说,伦理合理性也是有可能的。涉及健康志愿者的基础科学实验以及旨在确定可耐受剂量水平的“一期”药物试验通常会得到伦理审查委员会的批准;此外,它们从政府资助机构获得的指导特别要求它们权衡受试者面临的风险与受试者获得的益处,以及那些可能从实验中获得的知识中受益的人所获得的益处。如果仍存在一个疑问,那就是为什么仍然存在这样一种假设,即研究伦理要求为单个研究受试者提供“有利的风险效益比”。